Histopathologic and immunologic aspects of alphacor artificial corneal failure.

PURPOSE To describe the histopathologic and immunologic characteristics of late artificial corneal failure in a small series of patients who underwent AlphaCor implantation and to elucidate the mechanisms involved. DESIGN Clinicopathologic case series. METHODS Three patients were diagnosed with corneal melting during the late postoperative period and required the removal of the devices. The explanted devices embedded within the corneal tissues were examined by light microscopy, electron microscopy, and immunohistochemical studies. RESULTS Light microscopic examination of the specimens disclosed adequate biointegration with no foreign body response. Immunofluorescence studies of the skirt exhibited expression of inflammatory cytokines such as interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha), and some interferon gamma (IFN-gamma). The keratocytes stained positively for Thy-1 and smooth muscle actin but negatively for CD34. CONCLUSIONS Although these findings confirm the occurrence of biointegration, myofibroblastic differentiation of the ingrowing keratocytes is a prominent feature.

[1]  Celia R Hicks,et al.  AlphaCor: Clinical Outcomes , 2006, Cornea.

[2]  N. Mamalis,et al.  Histology of AlphaCor Skirts: Evaluation of Biointegration , 2005, Cornea.

[3]  C. Hicks,et al.  Melting after Keratoprosthesis Implantation: The Effects of Medroxyprogesterone , 2003, Cornea.

[4]  C. Traversi,et al.  CD-34 stromal expression pattern in normal and altered human corneas. , 2002, Ophthalmology.

[5]  S. Wilson,et al.  Proinflammatory chemokine induction in keratocytes and inflammatory cell infiltration into the cornea. , 2001, Investigative ophthalmology & visual science.

[6]  A. McDermott,et al.  Thy-1 distinguishes human corneal fibroblasts and myofibroblasts from keratocytes. , 2004, Experimental eye research.

[7]  I J Constable,et al.  Corneal replacement using a synthetic hydrogel cornea, AlphaCor™: device, preliminary outcomes and complications , 2003, Eye.

[8]  I. Constable,et al.  The Chirila Keratoprosthesis: phase I human clinical trial. , 2002, Ophthalmology.

[9]  M. Dana,et al.  Twenty-five–Year Panorama of Corneal Immunology: Emerging Concepts in the Immunopathogenesis of Microbial Keratitis, Peripheral Ulcerative Keratitis, and Corneal Transplant Rejection , 2000, Cornea.

[10]  M. Dana,et al.  Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[11]  E. Akpek,et al.  Current concepts and techniques in keratoprosthesis , 2005, Current opinion in ophthalmology.

[12]  I. Constable,et al.  Assessment of Anticollagenase Treatments After Insertion of a Keratoprosthetic Material in the Rabbit Cornea , 1998, Cornea.

[13]  Kunihiko Nakamura.  Interaction Between Injured Corneal Epithelial Cells and Stromal Cells , 2003, Cornea.

[14]  R. Phipps,et al.  Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts. , 2001, The American journal of pathology.

[15]  H. D. Cavanagh,et al.  Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. , 1996, Cornea.

[16]  I. Constable,et al.  Development and clinical assessment of an artificial cornea , 2000, Progress in Retinal and Eye Research.